Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07319767
Eligibility Criteria:
Inclusion Criteria:
1. Pathologically confirmed malignancy of one of the following types: biliary tract cancer (intrahepatic cholangiocarcinoma, hilar cholangiocarcinoma, or gallbladder cancer), breast cancer, or pancreatic ductal adenocarcinoma
2. Age 18 to 80 years (inclusive), any sex
3. Received neoadjuvant or conversion therapy before surgery; no prior anti-cancer therapy before that course
4. Underwent tumor surgical resection or biopsy after completion of neoadjuvant/conversion therapy
5. Available baseline and preoperative imaging with the same modality (contrast-enhanced CT or MRI) at both time points for response evaluation
6. Complete postoperative pathology report and follow-up data available
Exclusion Criteria:
1. History of another malignancy or concurrent multiple primary cancers
2. Missing imaging or inconsistent imaging evaluation across time points (e.g., absent scans or differing modalities that preclude paired assessment)
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT07319767
Study Brief:
Protocol Section:
NCT07319767